B-type Natriuretic Peptide (BNP) in Human Hypertension

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Hypertension Stage 1

Interventions

DRUG

brain natriuretic peptide

start 10 mcg/kg (2 participants), 7 mcg/kg (2 participants), 5 mcg/kg (2 participants) and 2 mcg/kg (2 participants)

OTHER

no-added salt diet

instruction to reduce salt for one week prior to study

Trial Locations (1)

Mayo Clinic, Rochester